A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn

Haematologica

Volumn 93, Issue 6, 2008, Pages 870-877

  Killie, Mette Kjær ^a   Husebekk, Anne ^a,b   Kjeldsen Kragh, Jens ^c   Skogen, Bjørn ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Anti HPA 1a; Neonatal alloimmune thrombocytopenia

Indexed keywords

HLA DR ANTIGEN; HLA DRB3 ANTIGEN; HUMAN PLATELET ANTIGEN 1A ANTIBODY; MATERNAL ANTIBODY; MONOCLONAL ANTIBODY; THROMBOCYTE ANTIGEN;

ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; GENE; GENE SEQUENCE; GESTATIONAL AGE; HLA DRB3 GENE; HUMAN; IMMUNIZATION; IMMUNOASSAY; LABORATORY TEST; MAJOR CLINICAL STUDY; PREGNANT WOMAN; PRIMIGRAVIDA; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT;

EID: 44949096249     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12515     Document Type: Article

References (30)

1. Blanchette VS, Johnson J, Rand M. The management of alloimmune neonatal thrombocytopenia. Bailliére's Best Pract Res Clin Haematol 2000;13:365-90.
2. Kaplan C, Daffos F, Forestier F, Morel MC, Chesnel N, Tchernia G. Current trends in neonatal alloimmune thrombocytopenia: diagnosis and therapy. In: Kaplan-Gouet C, Schlegel N, Salmon Ch, McGregor J, eds. Platelet Immunology: Fundamental and Clinical Aspects. Paris: Colloque INSERM/John Libbey Eurotext Ltd; 1991:267-78.
3. Spencer JA, Burrows RF. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Aust N Z J Obstet Gynaecol 2001; 41:45-55.
4. Williamson LM, Hackett G, Rennie J, Palmer CR, Maciver C, Hadfield R, et al. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood 1998;92:2280-7.
5. Jaegtvik S, Husebekk A, Aune B, Oian P, Dahl LB, Skogen B. Neonatal alloimmune thrombocytopenia due to anti-HPA 1a antibodies; the level of maternal antibodies predicts the severity of thrombocytopenia in the newborn. BJOG 2000;107:691-4.
6. Maslanka K, Guz K, Zupanska B. Antenatal screening of unselected pregnant women for HPA-1a antigen, antibody and alloimmune thrombocytopenia. Vox Sang 2003;85:326-7.
7. Radder CM, Kanhai HH, Brand A. On the mechanism of high dose maternal intavenous immunoglobulin (IVIG) in alloimmune thrombocytopenia. In: Radder CM, ed. Management of Fetal Alloimmune Thrombocytopenia. Amsterdam: PrintPartners Ipskamp; 2004. p.69-81.
8. Killie MK, Husebekk A, Kaplan C, Taaning E, Skogen B. Maternal human platelet antigen-1a antibody level correlates with the platelet count in the newborns: a retrospective study. Transfusion 2007;47:55-8.
9. Bertrand G, Martageix C, Jallu V, Vitry F, Kaplan C. Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia. J Thromb Haemost 2006;4:628-37.
10. Ghevaert C, Campbell K, Stafford P, Metcalfe P, Casbard A, Smith GA, et al. HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia. Transfusion 2007;47:1296-305.
11. Kjeldsen-Kragh J, Killie M, Tomter G, Golebiowska E, Randen I, Hauge R, et al. A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood 2007;110:833-9.
12. Killie MK, Kjeldsen-Kragh J, Randen I, Skogen B, Husebekk A. Evaluation of a new flow cytometric HPA 1a screening method. A rapid and reliable tool for HPA 1a screening of blood donors and pregnant women. Transfus Apher Sci 2004;30:89-92.
13. Weiss EJ, Goldschmidt-Clermont PJ, Grigoryev D, Jin Y, Kickler TS, Bray PF. A monoclonal antibody (SZ21) specific for platelet GPIIIa distinguishes P1A1 from P1A2. Tissue Antigens 1995;46:374-81.
14. Kjaer KM, Jaegtvik S, Husebekk A, Skogen B. Human platelet antigen 1 (HPA 1) genotyping with 5′ nuclease assay and sequence-specific primers reveals a single nucleotide deletion in intron 2 of the HPA 1a allele of platelet glycoprotein IIIa. Br J Haematol 2002;117:405-8.
15. Randen I, Sorensen K, Killie MK, Kjeldsen-Kragh J. Rapid and reliable genotyping of human platelet antigen (HPA)-1, -2, -3, -4, and -5 a/b and Gov a/b by melting curve analysis. Transfusion 2003;43:445-50.
16. Bertrand G, Jallu V, Gouet M, Kjaer KM, Lambin P, Husebekk A, Kaplan C. Quantification of human platelet antigen-1a antibodies with the monoclonal antibody immobilization of platelet antigens procedure. Transfusion 2005;45:1319-23.
17. Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 1987;70:1722-6.
18. Kiefel V. The MAIPA assay and its applications in immunohaematology. Transfus Med 1992;2:181-8.
19. Skogen B, Christiansen D, Husebekk A. Flow cytometric analysis in platelet cross-matching using a platelet suspension immunofluorescence test. Transfusion 1995;35:832-6.
20. Kotsch K, Wehling J, Blasczyk R. Sequencing of HLA class II genes based on the conserved diversity of the non-coding regions: sequencing based typing of HLA-DRB genes. Tissue Antigens 1999;53:486-97.
21. Swets JA. Measuring the accuracy of diagnostic systems. Science 1988; 240:1285-93.
22. Peat J, Barton B. Medical Atatistics: a Guide to Data Analysis and Critical Appraisal. Mediac. First ed. Oxford: Blackwell Publishing Ltd; 2005.
23. Glüer CC, Blake G, Lu Y, Blunt BA, Jergas M, Genant HK. Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques. Osteoporos Int 1995;5:262-70.
24. Vasserstats website for statistical calculations. www.faculty.vassar.edu/ lowry/VassaStats.html. Accessed May 5th 2007.
25. Birchall JE, Murphy MF, Kaplan C, Kroll H. European collaborative study of the antenatal management of fetomaternal alloimmune thrombocytopenia. Br J Haematol 2003;122:275-88.
26. Valentin N, Vergracht A, Bignon JD, Cheneau ML, Blanchard D, Kaplan C, et al. HLA-DRw52a is involved in alloimmunization against PL-A1 antigen. Hum Immunol 1990;27:73-9.
27. Ghevaert C, Campbell K, Walton J, Smith GA, Allen D, Williamson LM, et al. Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia. Transfusion 2007; 47:901-10.
28. Dawkins B. Monitoring anti-HPA-1a platelet antibody levels during pregnancy using the MAIPA test. Vox Sang 1995;68:27-34.
29. Goyenaga MH, Fromont P, Muller JY, Valentin N. A HPA -1a negative woman immunized against HPA-1a antigen by platelet transfusion gave birth to a healthy positive child after disparition of the anti-HPA 1a at the end of pregnancy. A case report. Lago Maggiore, Italy. 7th European symposium on platelet, granulocyte and red cell immunology, 2002.
30. Killie MK, Husebekk A, Kjeldsen-Kragh J, Skogen B. The natural course of anti-HPA 1a antibody levels in subsequent non-compatible pregnancies. Platelets 2004;15:250 [Abstract].